News and Announcements

Call for Editor-in-Chief of Reproductive Sciences

SRI is currently seeking an Editor-in-Chief to continue and build upon the remarkable success of Reproductive Sciences under the leadership of the current editor Dr Hugh Taylor. If you are interested in serving in this capacity, please forward your CV, vision statement for the journal, and a letter explaining your qualifications for this position to the following address:

Society for Reproductive Investigation
Attn: Editor Search Task Force
c/o Anne Krolikowski, Executive Director
555 E. Wells Street
Suite 1100
Milwaukee, WI 53202

Or electronically to

The ideal candidate will be an energetic individual with academic experience, membership in SRI and experience in reproductive medicine and women’s health who envisions taking this Journal to the next level. Your vision statement should include your goals and plans for the content of the Journal and may include an assessment of the current strengths, weaknesses, or gaps that you plan to address. The Editor-in-Chief will work closely with a dynamic team of individuals in the publishing and SRI offices. Mutually agreed upon compensation for the position will be discussed with candidates at the appropriate time.

The deadline for receipt of application materials is April 12, 2019. Alternatively, if you know of someone that you believe would be interested in this position, please forward this information. An Editor-In-Chief job description can be found on the SRI website.


The official publication of SRI, Reproductive Sciences (RS) is a leading international journal that serves to publish the latest advances in basic, clinical and translational science. RS is a peer-reviewed, monthly journal publishing original research and reviews in obstetrics and gynecology. RS is multi-disciplinary and includes research in basic reproductive biology and medicine, maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, urogynecology, fertility/infertility, embryology, gynecologic/reproductive oncology, developmental biology, stem cell research, molecular/cellular biology and other related fields. Average time to first decision: 34 days.